Role of phosphodiesterase-4 inhibitors in chronic obstructive pulmonary disease
Chin Kook Rhee, Deog Kyeom Kim
Korean J Intern Med. 2020;35(2):276-283. Published online 2020 Feb 28 DOI: https://doi.org/10.3904/kjim.2020.035
Citations to this article as recorded by 
Plant-based therapeutics for chronic obstructive pulmonary diseases: Nanoformulation strategies to overcome delivery challenges
Sofia Kokkinis, Manisha Singh, Keshav Raj Paudel, Gabriele De Rubis, Ayeh Bani Saeid, Victoria Jessamine, Jessica Datsyuk, Sachin Kumar Singh, Sukriti Vishwas, Jon Adams, Philip M. Hansbro, Brian Oliver, Gaurav Gupta, Harish Dureja, Kamal Dua
Food Bioscience.2024; 58: 103761. CrossRef
Phosphodiesterase-4 Inhibition in Parkinson’s Disease: Molecular Insights and Therapeutic Potential
Dhritiman Roy, Shivaramakrishnan Balasubramanian, Praveen Thaggikuppe Krishnamurthy, Piyong Sola, Emdormi Rymbai
Cellular and Molecular Neurobiology.2023; 43(6): 2713. CrossRef
The PDE4 Inhibitor Tanimilast Restrains the Tissue-Damaging Properties of Human Neutrophils
Tiziana Schioppa, Hoang Oanh Nguyen, Valentina Salvi, Norma Maugeri, Fabrizio Facchinetti, Gino Villetti, Maurizio Civelli, Carolina Gaudenzi, Mauro Passari, Francesca Sozio, Ilaria Barbazza, Nicola Tamassia, Marco A. Cassatella, Annalisa Del Prete, Danie
International Journal of Molecular Sciences.2022; 23(9): 4982. CrossRef
An Overview of PDE4 Inhibitors in Clinical Trials: 2010 to Early 2022
Letizia Crocetti, Giuseppe Floresta, Agostino Cilibrizzi, Maria Paola Giovannoni
Molecules.2022; 27(15): 4964. CrossRef
The Counter Regulatory Axis of the Lung Renin-Angiotensin System in Severe COVID-19: Pathophysiology and Clinical Implications
Filippos Triposkiadis, Randall C. Starling, Andrew Xanthopoulos, Javed Butler, Harisios Boudoulas
Heart, Lung and Circulation.2021; 30(6): 786. CrossRef
Updated view on the treatment of chronic obstructive pulmonary disease in Korea
Deog Kyeom Kim, Chin Kook Rhee
Journal of the Korean Medical Association.2021; 64(3): 225. CrossRef
Two Mixed-Ligand Co(II) Coordination Polymers: Treatment Activity on COPD via Reding the Activity of the AMPK Signaling Pathway
Hua Liu, Dan-Dan Tang, Xiao-Juan Yan
Journal of Inorganic and Organometallic Polymers and Materials.2021; 31(9): 3793. CrossRef
Inhaled Dual Phosphodiesterase 3/4 Inhibitors for the Treatment of Patients with COPD: A Short Review
Clémence Martin, Pierre-Régis Burgel, Nicolas Roche
International Journal of Chronic Obstructive Pulmonary Disease.2021; Volume 16: 2363. CrossRef
Prediction of gold stage in patients hospitalized with COPD exacerbations using blood neutrophils and demographic parameters as risk factors
Jing Chen, Zhao Yang, Qun Yuan, Li-quan Guo, Da-xi Xiong
BMC Pulmonary Medicine.2021;[Epub] CrossRef
Roflumilast in Severely Ill Patients with Chronic Obstructive Pulmonary Disease with Frequent Exacerbations: Risk of Pneumonia Hospitalization and Severe Exacerbations
Imane Achir Alispahic, Rikke Sørensen, Josefin Eklöf, Pradeesh Sivapalan, Anders Løkke, Niels Seersholm, Jakob Hedemark Vestergaard, Jens-Ulrik Stæhr Jensen
Journal of Clinical Medicine.2020; 9(5): 1442. CrossRef
New putative insights into neprilysin (NEP)-dependent pharmacotherapeutic role of roflumilast in treating COVID-19
Manar Mohammed El Tabaa, Maram Mohammed El Tabaa
European Journal of Pharmacology.2020; 889: 173615. CrossRef